CIK 0001042418 · Non-accelerated filer<br>Smaller reporting company
Inhibitor Therapeutics, Inc.
Sign in to watch- Ticker
- INTI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 541641133
- Phone
- (813) 766-2462
- Business address
- 4830 W. KENNEDY BLVD., SUITE 600, TAMPA, FL, 33609
- Former names
- HedgePath Pharmaceuticals, Inc., COMMONWEALTH BIOTECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-12-29 | HARRIS ROBERT B President | Grant or award | +25,000 | 70,064 | ||
| 2008-12-29 | FREER RICHARD J Chief Operating Officer | Grant or award | +25,000 | 200,474 | ||
| 2008-12-29 | BRENNAN JAMES H VP Financial Operations | Grant or award | +25,000 | 34,866 | ||
| 2008-09-25 | FREER RICHARD J COO | Purchase | +5,000 | $0.98 | $5K | 180,880 |
| 2008-09-12 | PharmAust Chemistry Ltd. 10% owner | Sale | −2,150,000 | $1.45 | $3.1M | 0 |
Page 9 of 9 · 165 trades